Recombinant Human E2F4 Protein, N-GST & C-His from ProteoGenix; catalogue ARO-P11359; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introduction to Recombinant Human E2F4 Protein
Recombinant Human E2F4 Protein is a key transcription factor that plays a crucial role in cell cycle regulation and cell proliferation. This protein is encoded by the E2F4 gene and belongs to the E2F family of transcription factors. It is a highly conserved protein found in both humans and other mammals, and is essential for normal cell growth and development.
Structure of Recombinant Human E2F4 Protein
The recombinant human E2F4 protein is a 414 amino acid long polypeptide with a molecular weight of approximately 47 kDa. It consists of several structural domains, including an N-terminal DNA binding domain, a dimerization domain, and a C-terminal transactivation domain. The DNA binding domain allows the protein to bind to specific DNA sequences, while the dimerization domain enables it to form complexes with other proteins. The transactivation domain is responsible for activating the expression of target genes.
Activity of Recombinant Human E2F4 Protein
The main function of recombinant human E2F4 protein is to regulate the expression of genes involved in cell cycle progression. It does this by binding to specific DNA sequences and either activating or repressing the transcription of target genes. E2F4 is known to interact with other proteins, such as retinoblastoma protein (pRB), to control the activity of cell cycle genes. This protein is also involved in the regulation of apoptosis, differentiation, and DNA repair.
Application of Recombinant Human E2F4 Protein
Recombinant human E2F4 protein has a wide range of applications in both research and therapeutic settings. One of its main uses is in studying the cell cycle and its regulation. Researchers can use this protein to investigate the role of E2F4 in cell proliferation and differentiation, as well as its interactions with other proteins involved in these processes.
Furthermore, recombinant human E2F4 protein has potential therapeutic applications in cancer treatment. Abnormal expression of E2F4 has been linked to various types of cancer, including breast, lung, and bladder cancer. By targeting E2F4, researchers hope to develop new treatments that can inhibit cancer cell growth and induce cell death.
Recombinant human E2F4 protein can also be used as an antigen in vaccine development. It has been shown to induce a strong immune response and can be used to develop vaccines against viral infections or cancer. Additionally, this protein can be used in diagnostic tests to detect the presence of E2F4 in patient samples, which can aid in the early detection and treatment of diseases.
Conclusion
In conclusion, recombinant human E2F4 protein is a crucial transcription factor involved in cell cycle regulation and cell proliferation. Its structure, activity, and applications make it a valuable tool in both research and therapeutic settings. By understanding the role of E2F4 in normal and disease processes, we can further advance our knowledge and develop new treatments for various diseases.
ProteoGenix catalogue number ARO-P11359. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 35.76 kDa; Fragment: Ser16-Lys82; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
